These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16167015

  • 1. Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
    Ferrara JL, Yanik G.
    Clin Adv Hematol Oncol; 2005 May; 3(5):415-9, 428. PubMed ID: 16167015
    [Abstract] [Full Text] [Related]

  • 2. [Graft vs host disease].
    Moalic V, Ferec C.
    Pathol Biol (Paris); 2006 May; 54(5):304-8. PubMed ID: 16530350
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology of graft-versus-host disease.
    Ferrara JL, Reddy P.
    Semin Hematol; 2006 Jan; 43(1):3-10. PubMed ID: 16412784
    [Abstract] [Full Text] [Related]

  • 4. Graft-versus-host disease: how to translate new insights into new therapeutic strategies.
    Devetten MP, Vose JM.
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):815-25. PubMed ID: 15570250
    [Abstract] [Full Text] [Related]

  • 5. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD.
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [Abstract] [Full Text] [Related]

  • 6. The pathophysiology of acute graft-versus-host disease.
    Jaksch M, Mattsson J.
    Scand J Immunol; 2005 May; 61(5):398-409. PubMed ID: 15882431
    [Abstract] [Full Text] [Related]

  • 7. Pathophysiology of acute graft-versus-host disease.
    Reddy P.
    Hematol Oncol; 2003 Dec; 21(4):149-61. PubMed ID: 14735553
    [Abstract] [Full Text] [Related]

  • 8. The role of cytokines in acute graft-versus-host disease.
    Hill GR, Krenger W, Ferrara JL.
    Cytokines Cell Mol Ther; 1997 Dec; 3(4):257-66. PubMed ID: 9740354
    [Abstract] [Full Text] [Related]

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 10. T cell immunity and graft-versus-host disease (GVHD).
    Ichiki Y, Bowlus CL, Shimoda S, Ishibashi H, Vierling JM, Gershwin ME.
    Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
    [Abstract] [Full Text] [Related]

  • 11. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 12. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB, Elkin G, Khitrin S, Slavin S.
    Exp Hematol; 2008 Dec 15; 36(12):1750-9. PubMed ID: 18809241
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
    Tian Y, Deng YB, Huang YJ, Wang Y.
    Immunol Invest; 2008 Dec 15; 37(1):29-42. PubMed ID: 18214798
    [Abstract] [Full Text] [Related]

  • 14. GVHD: overview on pathophysiology, incidence, clinical and biological features.
    Klingebiel T, Schlegel PG.
    Bone Marrow Transplant; 1998 Apr 15; 21 Suppl 2():S45-9. PubMed ID: 9630325
    [Abstract] [Full Text] [Related]

  • 15. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W, Kim J, Jung D, Kim H, Choi HJ, Cho HR, Kwon B.
    Biol Blood Marrow Transplant; 2009 Mar 15; 15(3):306-14. PubMed ID: 19203721
    [Abstract] [Full Text] [Related]

  • 16. Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
    Couriel D, Caldera H, Champlin R, Komanduri K.
    Cancer; 2004 Nov 01; 101(9):1936-46. PubMed ID: 15372473
    [Abstract] [Full Text] [Related]

  • 17. Acute GvHD: pathogenesis and classification.
    Ball LM, Egeler RM, EBMT Paediatric Working Party.
    Bone Marrow Transplant; 2008 Jun 01; 41 Suppl 2():S58-64. PubMed ID: 18545246
    [Abstract] [Full Text] [Related]

  • 18. Biological advances in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Duran-Struuck R, Reddy P.
    Transplantation; 2008 Feb 15; 85(3):303-8. PubMed ID: 18301323
    [Abstract] [Full Text] [Related]

  • 19. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E, Weiss L, Kasir J, Zeira M, Slavin S, Shapira MY.
    Bone Marrow Transplant; 2006 Sep 15; 38(5):359-64. PubMed ID: 16862165
    [Abstract] [Full Text] [Related]

  • 20. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R, Atkinson K, Hart DN, Munster DJ, Rice AM.
    Transplantation; 2008 Oct 15; 86(7):968-76. PubMed ID: 18852664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.